1 min read

Kura Oncology, Inc. (KURA) Discusses Clinical Updates on Farnesyl Transferase Inhibitor Programs and Combination Therapies in Oncology Transcript

Follow Play Earnings CallPlay Earnings Call Kura Oncology, Inc. (NASDAQ:KURA) Discusses Clinical Updates on Farnesyl Transferase Inhibitor Programs and Combination Therapies in Oncology October 18, 2025 1:30 PM EDT Company Participants Troy Wilson – Chairman, CEO & PresidentMollie Leoni – Chief Medical Officer Conference Call Participants Glenn J. HannaJonathan Chang – Leerink Partners LLC, Research […]